Free Trial

GENinCode (GENI) Competitors

GENinCode logo
GBX 1.60 +0.05 (+3.10%)
As of 11:20 AM Eastern

GENI vs. DIS, AMC, LION, SPHR, GVC, SONG, TKO, NFC, MCS, and RDI

Should you be buying GENinCode stock or one of its competitors? The main competitors of GENinCode include Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), Sphere Medical (SPHR), Entain PLC (GVC.L) (GVC), Hipgnosis Songs (SONG), Taseko Mines (TKO), Next Fifteen Communications Group (NFC), McCarthy & Stone (MCS), and Rdi Reit (RDI). These companies are all part of the "entertainment" industry.

GENinCode vs.

Distil (LON:DIS) and GENinCode (LON:GENI) are both small-cap consumer defensive companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, institutional ownership, earnings and analyst recommendations.

In the previous week, GENinCode had 1 more articles in the media than Distil. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Distil. GENinCode's average media sentiment score of 0.75 beat Distil's score of 0.00 indicating that GENinCode is being referred to more favorably in the news media.

Company Overall Sentiment
Distil Neutral
GENinCode Positive

0.0% of Distil shares are owned by institutional investors. Comparatively, 47.6% of GENinCode shares are owned by institutional investors. 60.2% of Distil shares are owned by insiders. Comparatively, 39.8% of GENinCode shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Distil has a net margin of -109.66% compared to GENinCode's net margin of -228.70%. Distil's return on equity of -22.94% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Distil-109.66% -22.94% -7.50%
GENinCode -228.70%-289.74%-63.99%

Distil has higher earnings, but lower revenue than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Distil£2.00M0.85-£2.19M-£0.13-0.83
GENinCode£2.67M1.06-£6.10M-£3.43-0.47

Distil has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, GENinCode has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500.

Distil received 39 more outperform votes than GENinCode when rated by MarketBeat users.

CompanyUnderperformOutperform
DistilOutperform Votes
39
68.42%
Underperform Votes
18
31.58%
GENinCodeN/AN/A

Summary

Distil and GENinCode tied by winning 7 of the 14 factors compared between the two stocks.

Get GENinCode News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GENI vs. The Competition

MetricGENinCodeDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£2.84M£786.60M£5.33B£2.66B
Dividend YieldN/A5.44%5.21%5.05%
P/E Ratio-0.472.0826.71129.21
Price / Sales1.06543.73386.12221,406.01
Price / Cash0.8311.4238.2528.02
Price / Book0.982.516.773.79
Net Income-£6.10M£286.34B£3.23B£5.88B
7 Day Performance-5.44%5.02%1.80%0.63%
1 Month Performance-33.47%2.57%11.10%22.11%
1 Year Performance-80.46%-10.28%17.11%120.87%

GENinCode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GENI
GENinCode
N/AGBX 1.60
+3.1%
N/A-80.9%£2.84M£2.67M-0.472,300News Coverage
Gap Up
DIS
Distil
N/AGBX 0.09
+5.9%
N/A-80.1%£1.39M£2.00M-0.68220,000Gap Down
AMC
Amur Minerals
N/AN/AN/AN/A£1.25MN/A-8.7533,700
LION
Lionsgold
N/AN/AN/AN/A£0.00N/A0.002,021
SPHR
Sphere Medical
N/AN/AN/AN/A£0.00N/A0.0010,900Gap Up
High Trading Volume
GVC
Entain PLC (GVC.L)
N/AN/AN/AN/A£6.08B£3.40B-38.7913,345
SONG
Hipgnosis Songs
N/AN/AN/AN/A£1.23B£124.41M-1,131.111
TKO
Taseko Mines
1.9936 of 5 stars
GBX 157.50
flat
GBX 222.50
+41.3%
N/A£853.34M£1.18B10.21N/A
NFC
Next Fifteen Communications Group
N/AN/AN/AN/A£787.02M£602.53M-974.3912,800Gap Up
MCS
McCarthy & Stone
N/AN/AN/AN/A£644.25M£621.43M21.397,500High Trading Volume
RDI
Rdi Reit
N/AN/AN/AN/A£462.34M£68.40M-4.442,020

Related Companies and Tools


This page (LON:GENI) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners